KeyBanc initiated coverage of BrightSpring Health with a Sector Weight rating as part of a broader research note launching coverage of Healthcare Services. The U.S. healthcare system requires significant efficiency gains and Healthcare Services will be at the epicenter of innovation, disruption, and opportunity, with near term proprietary hospital card data indicating that utilization remains strong in Q3 which represents a positive read for Hospitals and Post-Acute care, the analyst tells investors in a research note. The firm believes BrightSpring has “captured some of the cross-sell opportunity between its Pharmacy and Provider segments,” and sees a “significant long-term opportunity to provide pharmacy services to patients as they are discharged from customer SNF/IRFs.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health initiated with a Sector Weight at KeyBanc
- BrightSpring Health price target raised to $20 from $15 at BTIG
- BrightSpring Health price target raised to $18 from $15 at Guggenheim
- Dr. Steve Miller Joins BrightSpring Health’s Expanded Board
- BrightSpring Health appoints Steve Miller to board of directors
